Incidence of acute kidney injury and attributive mortality in acute respiratory distress syndrome randomized trials.
Edoardo AntonucciBruno GarciaDavid ChenMichael A MatthayKathleen D LiuMatthieu LegrandPublished in: Intensive care medicine (2024)
The incidence of AKI appears to be stable over time in patients with ARDS enrolled in randomized trials. The development of AKI remains a significant contributing factor to mortality. These estimates are essential for designing future clinical trials for AKI prevention or treatment.
Keyphrases
- placebo controlled
- acute kidney injury
- acute respiratory distress syndrome
- risk factors
- extracorporeal membrane oxygenation
- cardiac surgery
- phase ii
- mechanical ventilation
- phase iii
- clinical trial
- cardiovascular events
- current status
- randomized controlled trial
- intensive care unit
- type diabetes
- open label
- smoking cessation